Open Access. Powered by Scholars. Published by Universities.®
Cell and Developmental Biology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Cell and Developmental Biology
Investigating Three Novel Porphyrins For The Possible Treatment For Lung Cancer Using Red And White Light, Emmy Hipps
Investigating Three Novel Porphyrins For The Possible Treatment For Lung Cancer Using Red And White Light, Emmy Hipps
Scholars Day Conference
Photodynamic therapy (PDT) is a treatment method for various illnesses including cancer that uses a special drug, called a photosensitizer (PS). When a patient is injected with a PS, over time the PS is absorbed by the cancerous tumor. Light is then applied to area for treatment. The light then causes the drug to be activated, and singlet oxygen is produced that kills the cells. The PS in partnership with light causes cancer cells to undergo apoptosis. This research focuses on testing three novel water-soluble porphyrins, ZnTPPEA, H2TPP – TRIS, and H2TPPADIPA, as potential photosensitizing agents. All three novel photosensitizing …
Functional Analysis Provides Insight Into Missing Heritability, Scott L. Baughan, Michael A. Tainsky, Fatima Darwiche
Functional Analysis Provides Insight Into Missing Heritability, Scott L. Baughan, Michael A. Tainsky, Fatima Darwiche
Medical Student Research Symposium
Accurate ascertainment of genetic risk can be potentially lifesaving for patients who inherit cancer promoting mutations. However, even with the most extensive panel testing clinically available, a large number of patients will test negative despite family history of cancer or test positive for a variant of unknown significance (VUS). For these patients, clinical management is complicated; patients want to know their risk, and may fear disease they are not at great risk for (benign VUS) or they may not be given access to potentially lifesaving early screening procedures (pathogenic VUS). ATM has proven a challenge to clinicians due to its …